US51

US pharma tariffs would raise US drug costs by US$51 billion annually, report finds
[ad_1] [LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, boosting US prices by as much as 12.9 per...
Saudi Arabia’s PIF signs MoUs worth up to US$51 billion with Japanese banks
[ad_1] SAUDI Arabia’s sovereign wealth fund, the Public Investment Fund (PIF), has signed five Memorandums of Understanding (MoU) with Japanese financial institutions worth up to an overall US$51 billion, it...